Therapeutic Bundle

New Drug Update
Pain Management

New Drug Update Part 1 & Part 2

Recorded April 27, 2023. This course is course is valid until April 27, 2026 and may be taken for credit up to that time.

Learning Objectives:

1. Identify recent FDA drug communications, including but not limited to, labeling changes, warnings, new indications, new dosage forms and MedWatch alerts.

2. Discuss the new drugs with respect to their pharmacology, pharmacokinetics, approved and unapproved indications.

3. Describe their adverse effects and drug interaction that may affect patient compliance.

4. Compare efficacy, dosage and cost to existing agent

5. Discuss the patient oriented outcomes or evidence that may or may not exist for each of the new medications and when they may or may not be appropriate to recommend for selected patients.

6. Compare pharmacotherapy outcomes vs cost/benefit between newly approved agents and existing or lower cost agents.

Opioids and Alternatives- Strategies to Optimize Success

Recorded Dec 09, 2022. This course is course is valid until Dec 09, 2022 and may be taken for credit up to that time.

Learning Objectives:

1.Describe how the role for the use of opioids in acute, chronic, cancer/palliative care and end-of-life pain has changed in the past decade.

2.Describe the key features of the 2022 Proposed CMS Recommendations/Guidelines for prescribing opioids for outpatients.

3.Differentiate addiction, physical dependency, and tolerance.

4.State key principles managing patients with ongoing therapy that includes opioid analgesics, including stating “red flags” for opioid misuse, abuse and diversion, and how to anticipate and manage adverse drug events.

5.Identify the main characteristics of patients who would be identified as "high risk", "moderate risk" and "low risk" for chronic opioid use.

6.State the definition of "hyperalgesia" and how to prevent/minimize this from negative- ly influencing the care of patients who are receiving opioids.

7.State three reasons why opioids may not be effective for some patients with chronic pain.

8.State key educational principles that should be applied to all patients and caregivers regarding the safe use, proper storage and disposal of opioids.

9.Compare and contrast the pharmacological benefits and risks of the following non-opioid pharmacological options for managing pain: a) cannabinoids; b) NSAIDS; c) anti- convulsants; and, d) anti-depressants.

Dr. C. Wayne Weart | Pharm.D., BCPS, FASHP

Professor Emeritus of Family Medicine, Department of Family Medicine, Medical University of South Carolina, Professor Emeritus of Clinical Pharmacy & Outcome Sciences, South Carolina College of Pharmacy, MUSC Campus, Charleston, SC.

Dr. Gregory Holmquist

Dr. Holmquist received his undergraduate and graduate degrees from the School of Pharmacy at the University of Washington in Seattle. He is a board certified Oncology Pharmacist, an American Medical Association Certified Educator for Physicians on Endof-Life Care, and an American Society of Pain Educators Certified Pain Educator (C.P.E.). As a clinician and educator, Dr. Holmquist’s philosophy of care is summarized in one core statement, “Making a difference in the lives of patients”

PHYSICIANS / PHYSICIAN ASSISTANTS/ MEDICAL PROFESSIONALS: Accreditation: In support of improving patient care, this activity has been planned and implemented by Continuing Education, Inc. and InPharmX dba University Learning Systems. Continuing Education, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC),to provide continuing education for the healthcare team.” Physician Designation: Continuing Education, Inc. designates this activity for 8 AMA PRA Category 1 Credits

PHARMACISTS :University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. These programs are accredited for pharmacists.

  • Session 1A 0741-0000-24-0001-H08-P APPLICATION

  • Session 2A 0741-0000-24-0003-H08-P APPLICATION

  • Session 3A 0741-0000-24-0005-H08-P APPLICATION

NURSE PRACTITIONERS/ NURSES: This course provides 8 contact hours (0.8 CEU) to fulfill the pharmacotherapeutics/ pharmacology requirements for American Nurses Credentialing Center (ANCC) Category 1 Continuing Education Hours  for certification renewal. The same hours submitted to renew certification may be submitted to a State Board of Nursing for re-licensure. American Nurses Credentialing Center (ANCC) accepts formally approved continuing education sponsored by organizations accredited or approved by the Accreditation Council for Pharmacy Education (ACPE). California Board of Registered Nursing Provider: CEP11409.

CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.

OTHER HEALTH PROFESSIONALS: Contact your respective board regarding approval.

CE Broker Tracking #50-11357

These courses were recorded January 9-11, 2024 and are valid for credit until January 9, 2027.